The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The relationship between patient-reported distress and healthcare utilization in mNSCLC.
 
Monica Himaani Bodd
No Relationships to Disclose
 
Susan C. Locke
Research Funding - BMS
 
Kris W. Herring
No Relationships to Disclose
 
Jesse D Troy
Honoraria - Gamida Cell; Navitas Clinical Research; Synthetic Biologics
Consulting or Advisory Role - Gamida Cell
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Cryo-Cell International; Sino Cell Technologies
 
Steven Wolf
No Relationships to Disclose
 
Jeffrey Melson Clarke
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca; G1 Therapeutics; Genentech; Guardant Health; Merck; NGM Biopharmaceuticals; Novartis; Pfizer; Spectrum Pharmaceuticals; Turning Point Therapeutics; Vivacitas Oncology
Speakers' Bureau - AstraZeneca; Merck
Research Funding - Abbvie; Achilles Therapeutics; Adaptimmune; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Cellular Biomedicine Group; Genentech; GlaxoSmithKline; Grid Therapeutics; Moderna Therapeutics; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Merck; NGM Biopharmaceuticals; Pfizer
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina
 
Thomas William LeBlanc
Honoraria - Abbvie; Astellas Pharma
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; Flatiron Health; GlaxoSmithKline; Pfizer; Seagen
Speakers' Bureau - Abbvie; Agios; Bristol-Myers Squibb/Celgene
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Jazz Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate Inc., royalty
Travel, Accommodations, Expenses - Abbvie/Genentech; Agios; Bristol-Myers Squibb/Celgene